COMPANY     TECHNOLOGY     INVESTORS     NEWS     CONTACT US
EnWave Corporation is a life sciences R&D company developing commercial applications for our Radiant Energy Vacuum (REV) technology. Developed in conjunction with the University of British Columbia, REV is used to dehydrate liquid pharmaceuticals and food products. Our goal is to replace the industry standard of freeze-drying, which is an expensive and labour intensive process.

bioREV for liquid pharmaceuticals

Designed for the dehydration of liquid pharmaceuticals containing sensitive biological material such as vaccines and antibodies. bioREV is being tested for feasibility in producing room temperature stable vaccines and antibodies that can be shipped worldwide without refrigeration, and stockpiled to protect against pandemic diseases and bioterrorism.


nutraREV for food

Designed for the dehydration of fruits, vegetables, nutraceuticals and food cultures such as probiotics and enzymes, to provide higher nutritional content and improved appearance and flavour over conventional methods. A commercial-scale nutraREV machine is currently being tested by a food industry partner to determine the commercial viability of this technology.  
 
Latest Price 0.39 +
May 7, 08 • EnWave Changes Terms of Private Placement
READ MORE
 
May 6, 08 • EnWave Announces Private Placement
READ MORE
 
May 1, 08 • EnWave Receives Positive Shelf-Life Results from Vaccine Dehydration Testing
READ MORE
Corporate Fact
Sheet
(PDF)
Corporate Presentation (PDF)
Legal Disclaimer | © 2008 All rights reserved